| Literature DB >> 24863348 |
Wan-Ying Wu1, Jin-Jun Hou1, Hua-Li Long1, Wen-Zhi Yang1, Jian Liang1, De-An Guo2.
Abstract
Over the past 30 years, China has significantly improved the drug development environment by establishing a series of policies for the regulation of new drug approval. The regulatory system for new drug evaluation and registration in China was gradually developed in accordance with international standards. The approval and registration of TCM in China became as strict as those of chemical drugs and biological products. In this review, TCM-based new drug discovery and development are introduced according to the TCM classification of nine categories.Keywords: China; China Food and Drug Administration (CFDA); Drug development; Drug discovery; Regulatory classification; Traditional Chinese Medicine
Mesh：
Substances：
Year: 2014 PMID： 24863348 DOI： 10.1016/S1875-5364(14)60050-9
Source DB: PubMed Journal: Chin J Nat Med ISSN： 1875-5364